Injection Site Lumps on GLP-1: What They Mean
You press on the area where you injected your GLP-1 medication and feel a small lump beneath the skin. It might be tender, slightly raised, or just noticeable when you touch it. Is this normal? Should you be concerned? In most cases, injection site lumps are harmless and temporary — but knowing what to look for and when to seek help keeps you safe.
Medical Disclaimer: This article is for informational purposes only. If an injection site shows signs of infection (spreading redness, warmth, pus, fever), contact your healthcare provider promptly.
Types of Injection Site Lumps
Not all lumps are the same. Understanding the type helps determine whether action is needed:
1. Medication Depot (Most Common)
GLP-1 medications are designed to be absorbed slowly from the subcutaneous tissue. Sometimes, the injected medication pools in a small area before fully dispersing, creating a palpable lump or nodule. These are typically:
- Pea-sized to marble-sized
- Slightly firm but not hard
- Not particularly painful (may be mildly tender)
- Resolve within 3-7 days as the medication absorbs
This is especially common when injecting cold medication (straight from the refrigerator), injecting too quickly, or using a site that has less subcutaneous fat.
2. Localized Inflammatory Reaction
Your immune system may react to the injected substance with mild, localized inflammation. This appears as:
- A raised, red, or pink area around the injection site
- Warmth and mild tenderness
- Possible slight itching
- Usually resolves within 24-72 hours
Inflammatory reactions occur in approximately 3-7% of GLP-1 users. They are more common in the first few weeks of treatment and tend to decrease with subsequent injections as the body adapts.
3. Lipohypertrophy
Lipohypertrophy is the accumulation of fatty tissue at frequently used injection sites. It develops over months of repeated injections in the same area. Characteristics:
- Larger, softer lumps (rubber-like consistency)
- Usually painless
- May not resolve on their own for months or years
- Can impair medication absorption, affecting efficacy
This is largely preventable through proper injection site rotation and is more common in patients who also use insulin.
4. Lipoatrophy (Rare)
The opposite of lipohypertrophy — lipoatrophy is the loss of subcutaneous fat at injection sites, creating indentations or depressions. This is rare with modern GLP-1 formulations but can occur. The affected areas may take months to fill in naturally.
5. Infection (Rare but Serious)
Injection site infections are uncommon with proper technique but require prompt medical attention. Signs include:
- Increasing redness that spreads outward from the injection site
- Progressive swelling and pain that worsen over 2-3 days
- Warmth to the touch that increases rather than decreases
- Pus, drainage, or a fluid-filled blister
- Red streaks extending from the site (lymphangitis)
- Fever or chills
Injection Technique to Prevent Lumps
Temperature
Always allow your medication to reach room temperature before injecting. Remove the pen from the refrigerator 15-30 minutes before your injection. Cold medication is more viscous, does not disperse as well in subcutaneous tissue, and is more likely to cause pain and lumps.
Site Selection
The three approved injection areas are:
- Abdomen: Most commonly used. Inject at least 2 inches from the navel. Avoid the waistband area.
- Thigh: Front or outer thigh. Avoid the inner thigh and areas near the knee.
- Upper arm: Back of the upper arm. May require assistance to reach.
Site Rotation System
The most important prevention strategy is systematic rotation. Here is a practical system:
- Divide each injection area into quadrants — for example, upper right abdomen, upper left abdomen, lower right abdomen, lower left abdomen
- Use a different quadrant each week — this gives each area at least 4 weeks to recover
- Keep a rotation log: Note the date and specific location of each injection
- Space injections at least 1 inch apart within the same general area
- Never inject into a lump, bruise, scar, or area of broken skin
Injection Technique
- Clean the site with an alcohol swab and let it dry completely before injecting
- Pinch the skin (if you have limited subcutaneous tissue) to create a fold for the needle
- Insert at 90 degrees for most patients. Thinner patients may need 45 degrees.
- Inject slowly: Take 5-10 seconds to press the plunger. Rushing increases the chance of a depot lump.
- Hold for 10 seconds after the plunger is fully depressed before removing the needle. This allows the medication to begin dispersing.
- Do not massage the site immediately after injection — wait at least 1 hour
- Do not rub or scratch the site, even if it itches
Treating Existing Lumps
For Medication Depot or Inflammatory Lumps
- Warm compress: Apply a warm (not hot) washcloth or heating pad to the area for 10-15 minutes, 2-3 times daily. Heat increases blood flow and helps the medication absorb.
- Gentle massage: After 24 hours, gently massage the area in circular motions to help disperse the medication. Do not apply heavy pressure.
- Time: Most lumps resolve within 3-14 days without intervention.
- OTC antihistamine: If there is itching or hive-like reaction, an oral antihistamine (cetirizine, loratadine) can provide relief.
For Lipohypertrophy
- Stop injecting in the affected area immediately
- Use alternative sites for all future injections
- The area may take 3-6 months or longer to fully resolve
- In severe cases, your provider may refer to dermatology
Allergic Reactions vs. Normal Site Reactions
It is important to distinguish between a normal local reaction and an allergic response:
Normal Local Reaction
- Redness and swelling limited to a small area (quarter-sized or smaller)
- Resolves within 24-72 hours
- Does not worsen with subsequent injections
- No systemic symptoms (no fever, no hives elsewhere)
Possible Allergic Reaction (Seek Medical Attention)
- Large area of redness or swelling (palm-sized or larger)
- Hives or rash spreading beyond the injection site
- Itching or swelling in other body areas
- Difficulty breathing or throat tightness
- Reactions that worsen with each injection
True allergic reactions to GLP-1 medications are rare but do occur. If you suspect an allergic reaction, contact your healthcare provider before your next scheduled injection.
Bruising at Injection Sites
Bruising is a separate issue from lumps but frequently accompanies injection site concerns. Small bruises are common and harmless. To minimize bruising:
- Do not inject into visible veins or areas with visible blood vessels
- Apply gentle pressure (without rubbing) for 30-60 seconds after removing the needle
- Avoid aspirin, ibuprofen, and fish oil supplements on injection day if bruising is a recurring issue (discuss with provider first)
- If you bruise very easily, mention this to your provider to rule out bleeding disorders
Key Takeaways
- Small injection site lumps are common and usually resolve within 3-14 days
- Most lumps are medication depots or mild inflammatory reactions — both are harmless
- Prevention centers on proper injection technique: room temperature medication, slow injection, and systematic site rotation
- Lipohypertrophy develops from repeated use of the same injection site — rotate religiously
- Warm compresses and gentle massage help existing lumps resolve faster
- Signs of infection (spreading redness, pus, fever) or allergic reaction (hives, swelling, breathing difficulty) require medical attention
Medical Disclaimer: This content is for informational purposes only and should not replace professional medical advice. Consult your healthcare provider about any injection site concerns, especially signs of infection or allergic reaction.
More on Side Effects
First Week on GLP-1: Hour-by-Hour Side Effects Timeline
What to expect during your first injection and the days that follow.
Managing Side Effects During Dose Titration: Week-by-Week Guide
Navigate each phase of dose escalation with fewer side effects.
Managing GLP-1 Medication Side Effects: Complete Guide
Comprehensive strategies for all common GLP-1 side effects.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).